全文获取类型
收费全文 | 112658篇 |
免费 | 31340篇 |
国内免费 | 1135篇 |
专业分类
耳鼻咽喉 | 2504篇 |
儿科学 | 3163篇 |
妇产科学 | 2712篇 |
基础医学 | 5280篇 |
口腔科学 | 5356篇 |
临床医学 | 27368篇 |
内科学 | 27612篇 |
皮肤病学 | 3573篇 |
神经病学 | 14045篇 |
特种医学 | 3969篇 |
外科学 | 19128篇 |
综合类 | 234篇 |
现状与发展 | 40篇 |
一般理论 | 28篇 |
预防医学 | 15022篇 |
眼科学 | 2497篇 |
药学 | 2064篇 |
中国医学 | 43篇 |
肿瘤学 | 10495篇 |
出版年
2024年 | 105篇 |
2023年 | 5145篇 |
2022年 | 1170篇 |
2021年 | 3170篇 |
2020年 | 5642篇 |
2019年 | 2494篇 |
2018年 | 7390篇 |
2017年 | 7710篇 |
2016年 | 8357篇 |
2015年 | 8510篇 |
2014年 | 11022篇 |
2013年 | 13003篇 |
2012年 | 5061篇 |
2011年 | 4803篇 |
2010年 | 7522篇 |
2009年 | 9729篇 |
2008年 | 4643篇 |
2007年 | 3514篇 |
2006年 | 4560篇 |
2005年 | 3070篇 |
2004年 | 2350篇 |
2003年 | 2075篇 |
2002年 | 1848篇 |
2001年 | 1926篇 |
2000年 | 1201篇 |
1999年 | 1768篇 |
1998年 | 2171篇 |
1997年 | 1945篇 |
1996年 | 2011篇 |
1995年 | 1785篇 |
1994年 | 1170篇 |
1993年 | 999篇 |
1992年 | 798篇 |
1991年 | 707篇 |
1990年 | 557篇 |
1989年 | 567篇 |
1988年 | 533篇 |
1987年 | 431篇 |
1986年 | 416篇 |
1985年 | 360篇 |
1984年 | 318篇 |
1983年 | 361篇 |
1982年 | 310篇 |
1981年 | 257篇 |
1980年 | 174篇 |
1979年 | 114篇 |
1978年 | 167篇 |
1977年 | 149篇 |
1976年 | 121篇 |
1974年 | 116篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
41.
42.
Cheryl L. Rock PhD RD Cynthia A. Thomson PhD RD Kristen R. Sullivan MS MPH Carol L. Howe MD MLS Lawrence H. Kushi ScD Bette J. Caan DrPH Marian L. Neuhouser PhD RD Elisa V. Bandera MD PhD Ying Wang PhD Kimberly Robien PhD RD Karen M. Basen-Engquist PhD MPH Justin C. Brown PhD Kerry S. Courneya PhD Tracy E. Crane PhD RDN David O. Garcia PhD FACSM Barbara L. Grant MS RDN CSO FAND Kathryn K. Hamilton MA RDN CSO CDN FAND Sheri J. Hartman PhD Stacey A. Kenfield ScD Maria Elena Martinez PhD Jeffrey A. Meyerhardt MD MPH Larissa Nekhlyudov MD MPH Linda Overholser MD Alpa V. Patel PhD Bernardine M. Pinto PhD Mary E. Platek PhD RD CDN Erika Rees-Punia PhD MPH Colleen K. Spees PhD MEd RD LD FAND Susan M. Gapstur PhD Marjorie L. McCullough ScD RD 《CA: a cancer journal for clinicians》2022,72(3):230-262
The overall 5-year relative survival rate for all cancers combined is now 68%, and there are over 16.9 million survivors in the United States. Evidence from laboratory and observational studies suggests that factors such as diet, physical activity, and obesity may affect risk for recurrence and overall survival after a cancer diagnosis. The purpose of this American Cancer Society guideline is to provide evidence-based, cancer-specific recommendations for anthropometric parameters, physical activity, diet, and alcohol intake for reducing recurrence and cancer-specific and overall mortality. The audiences for this guideline are health care providers caring for cancer survivors as well as cancer survivors and their families. The guideline is intended to serve as a resource for informing American Cancer Society programs, health policy, and the media. Sources of evidence that form the basis of this guideline are systematic literature reviews, meta-analyses, pooled analyses of cohort studies, and large randomized clinical trials published since 2012. Recommendations for nutrition and physical activity during cancer treatment, informed by current practice, large cancer care organizations, and reviews of other expert bodies, are also presented. To provide additional context for the guidelines, the authors also include information on the relationship between health-related behaviors and comorbidities, long-term sequelae and patient-reported outcomes, and health disparities, with attention to enabling survivors' ability to adhere to recommendations. Approaches to meet survivors' needs are addressed as well as clinical care coordination and resources for nutrition and physical activity counseling after a cancer diagnosis. 相似文献
43.
44.
We read with interest the commentary by Skeldon and Dijk about our article “Weekly, seasonal and chronotype-dependent variation of dim light melatonin onset.” The discussion points raised by Skeldon and Dijk are currently among the most hotly debated in human circadian science. What external factors determine human phase of entrainment? How great is the contribution of natural versus artificial light and sun time versus social time? Our intra-individual data add to the still limited evidence from field studies in this matter. In their commentary, Skeldon and Dijk formulate two either-or hypotheses, postulating that humans entrain either solely to the natural light-dark cycle (sun time referenced by midday) (H1) or solely to the light selected by local clock time and social constraints (H2). Neither hypothesis accounts for the effect of season on human light exposure. We interpreted our findings along more complex lines, speculating that the 1-h earlier melatonin rise in summer found in our sample is likely the combined result of daylight saving time (DST)-induced behavioral advances and a stronger natural zeitgeber in summer (light exposure determined by social and seasonal factors, Horiginal). Here, we show how the criticism by Skeldon and Dijk is based on two sentences quoted out of context (misrepresenting our hypothesis as H1) and that their hypothesis H2 leaves out important seasonal components in light exposure. 相似文献
45.
Naveen Pemmaraju MD Jacqueline S. Garcia MD Andrew Perkins MBBS PhD Jason G. Harb PhD Andrew J. Souers PhD Michael E. Werner PhD Christopher M. Brown PhD Francesco Passamonti MD 《Cancer》2023,129(22):3535-3545
Myelofibrosis is a heterogeneous myeloproliferative neoplasm characterized by chronic inflammation, progressive bone marrow failure, and hepatosplenic extramedullary hematopoiesis. Treatments like Janus kinase inhibitor monotherapy (e.g., ruxolitinib) provide significant spleen and symptom relief but demonstrate limited ability to lead to a durable disease modification. There is an urgent unmet medical need for treatments with a novel mechanism of action that can modify the underlying pathophysiology and affect the disease course of myelofibrosis. This review highlights the role of B-cell lymphoma (BCL) protein BCL-extra large (BCL-XL) in disease pathogenesis and the potential role that navitoclax, a BCL-extra large/BCL-2 inhibitor, may have in myelofibrosis treatment. 相似文献
46.
47.
48.
Yan Gao MD Yizhen Liu MD PhD Yafei Wang MD Qingyuan Zhang MD Depei Wu MD Xu Ye MD Jianqiu Wu MD Wei Xu MD Jianfeng Zhou MD Yu Yang MD Hong Cen MD Feng Zhang MD Ying Xiang MD Xiaoqiong Tang MD Kaiyang Ding MD JinYing Lin MD Lei Ma MD Shunqing Wang MD Hao Yu MD Yang Zhao MD Bin Song MD Fangfang Lv MD Huiqiang Huang MD 《Cancer》2023,129(4):551-559
49.
50.